PSNL (Personalis, Inc.) Stock Financials & Earnings | Market Cap Arena

PSNL (Personalis, Inc.) Stock Financials & Earnings | Market Cap Arena

PSNLPersonalis, Inc.

Mkt Cap$736M

Healthcare·Medical - Diagnostics & Research·🇺🇸 United States·NASDAQ

Revenue (TTM)$70M

Net Income (TTM)-$81M

EPS (TTM)-$0.91

Free Cash Flow (TTM)-$79M

Gross Margin22.7%

Op. Margin-126.4%

Net Margin-116.7%

FCF Margin-114.1%

P/S Ratio (TTM)10.6x

P/E Ratio (TTM)—

YoY Rev Growth-17.7%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$19M	$5M	-$30M
Q2 23	$17M	$5M	-$25M
Q3 23	$18M	$3M	-$31M
Q4 23	$20M	$5M	-$24M
Q1 24	$20M	$5M	-$19M
Q2 24	$23M	$8M	-$17M
Q3 24	$26M	$9M	-$14M
Q4 24	$17M	$5M	-$18M
Q1 25	$21M	$7M	-$18M
Q2 25	$17M	$5M	-$22M
Q3 25	$14M	$2M	-$23M
Q4 25	$17M	$2M	-$25M

Valuation

Quarter	P/S	P/E
Q1 23	10.7x	—
Q2 23	11.0x	—
Q3 23	10.4x	—
Q4 23	10.0x	—
Q1 24	9.9x	—
Q2 24	9.2x	—
Q3 24	8.4x	—
Q4 24	8.7x	—
Q1 25	8.6x	—
Q2 25	9.2x	—
Q3 25	10.6x	—
Q4 25	10.6x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$16M	-$20M
Q2 23	-$10M	-$13M
Q3 23	-$17M	-$18M
Q4 23	-$13M	-$17M
Q1 24	-$20M	-$21M
Q2 24	-$11M	-$11M
Q3 24	-$6M	-$6M
Q4 24	-$8M	-$9M
Q1 25	-$18M	-$20M
Q2 25	-$13M	-$13M
Q3 25	-$22M	-$23M
Q4 25	-$22M	-$22M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$4M
Q2 23	$3M
Q3 23	$868K
Q4 23	$4M
Q1 24	$104K
Q2 24	$6K
Q3 24	$247K
Q4 24	$1M
Q1 25	$3M
Q2 25	$290K
Q3 25	$2M
Q4 25	$77K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	+23.9%	+11.8%
Q2 23	-8.4%	-8.8%
Q3 23	+22.8%	+16.4%
Q4 23	+17.7%	-10.6%
Q1 24	+3.5%	-21.1%
Q2 24	+35.2%	-6.1%
Q3 24	+40.9%	-18.2%
Q4 24	-14.6%	-20.0%
Q1 25	+5.5%	-0.3%
Q2 25	-23.8%	-1.2%
Q3 25	-43.6%	-5.7%
Q4 25	+3.2%	+22.1%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$4M	19.6%
Q2 23	$3M	20.9%
Q3 23	$3M	19.1%
Q4 23	$3M	17.2%
Q1 24	$3M	13.8%
Q2 24	$3M	11.7%
Q3 24	$3M	10.4%
Q4 24	$3M	15.9%
Q1 25	$2M	10.8%
Q2 25	$3M	16.5%
Q3 25	$2M	14.4%
Q4 25	$2M	13.2%

OpEx Breakdown

Quarter	R&D	SG&A
Q1 23	$17M	$14M
Q2 23	$18M	$12M
Q3 23	$17M	$12M
Q4 23	$14M	$12M
Q1 24	$13M	$12M
Q2 24	$13M	$12M
Q3 24	$12M	$11M
Q4 24	$11M	$11M
Q1 25	$13M	$12M
Q2 25	$12M	$14M
Q3 25	$12M	$13M
Q4 25	$13M	$14M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$87M	$62M	$149M
Q2 23	$97M	$40M	$137M
Q3 23	$72M	$48M	$121M
Q4 23	$57M	$57M	$114M
Q1 24	$44M	$51M	$95M
Q2 24	$48M	$39M	$87M
Q3 24	$76M	$68M	$144M
Q4 24	$91M	$94M	$185M
Q1 25	$71M	$115M	$186M
Q2 25	$53M	$120M	$173M
Q3 25	$50M	$101M	$151M
Q4 25	$124M	$116M	$240M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	47M	+1.0%
Q2 23	48M	+2.0%
Q3 23	49M	+2.1%
Q4 23	49M	+1.5%
Q1 24	51M	+2.5%
Q2 24	52M	+3.4%
Q3 24	61M	+16.5%
Q4 24	73M	+19.4%
Q1 25	87M	+20.0%
Q2 25	89M	+1.2%
Q3 25	89M	+0.2%
Q4 25	92M	+4.0%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 17	—	—
FY 18	—	—
FY 19	$358K	182
FY 20	$335K	235
FY 21	$262K	326
FY 22	$163K	399
FY 23	$184K	399
FY 24	$369K	229
FY 25	$0	260